In addition, deletions of MYO16 and ATP1B genes have been also noted in additional unrelated patients with neurodevelopmental disorders (NDDs) in other published studies (Table 3) ([8–10] and see acknowledgments for details). This evidence concerns the gene MYO16 and neurodevelopmental disorder.